The von willeb teines are essential for secretion

Journal of Thrombosis and Haemostasis

Volumn 12, Issue 2, 2014, Pages 246-254

  Shapiro, S E ^a   Nowak, A A ^a   Wooding, C ^a   Birdsey, G ^b   Laffan, M A ^a   Mckinnon, T A J ^a  

^a Faculty of Medicine   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Cysteine; Mutagenesis; Oxidoreductases; Von Willebrand disease; Von Willebrand factor

Indexed keywords

ALANINE; CYSTEINE DERIVATIVE; VON WILLEBRAND FACTOR; CYSTEINE; OXIDOREDUCTASE;

ARTICLE; CELL LYSATE; CONTROLLED STUDY; DELETION MUTANT; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MUTATION; POINT MUTATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS; WILD TYPE; CHEMISTRY; GENETICS; HEK293 CELL LINE; MASS SPECTROMETRY; METABOLISM; MUTAGENESIS; VON WILLEBRAND DISEASE;

CYSTEINE; MUTAGENESIS; OXIDOREDUCTASES; VON WILLEBRAND DISEASE; VON WILLEBRAND FACTOR;

CYSTEINE; HEK293 CELLS; HUMANS; MASS SPECTROMETRY; MUTATION; VON WILLEBRAND FACTOR;

EID: 84893543601     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/jth.12466     Document Type: Article

References (28)

1. Miseta A, Csutora P. Relationship between the occurrence of cysteine in proteins and the complexity of organisms. Mol Biol Evol 2000; 17: 1232-9.
2. Wagner DD, Marder VJ. Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization. J Cell Biol 1984; 99: 2123-30.
3. Xie L, Chesterman CN, Hogg PJ. Reduction of von Willebrand factor by endothelial cells. Thromb Haemost 2000; 84: 506-13.
4. Ganderton T, Berndt MC, Chesterman CN, Hogg PJ. Hypothesis for control of von Willebrand factor multimer size by intramolecular thiol-disulfide exchange. J Thromb Haemost 2007; 5: 204-6.
5. Choi H, Aboulfatova K, Pownall HJ, Cook R, Dong JF. Shear-induced disulfide bond formation regulates adhesion activity of von Willebrand factor. J Biol Chem 2007; 282: 35604-11.
6. Ganderton T, Wong JW, Schroeder C, Hogg PJ. Lateral self-association of VWF involves the Cys2431-Cys2453 disulfide/dithiol in the C2 domain. Blood 2011; 118: 5312-18.
7. Zhou YF, Eng ET, Zhu J, Lu C, Walz T, Springer TA. Sequence and structure relationships within von Willebrand factor. Blood 2012; 120: 449-58.
8. O'Leary JM, Hamilton JM, Deane CM, Valeyev NV, Sandell LJ, Downing AK. Solution structure and dynamics of a prototypical chordin-like cysteine-rich repeat (von Willebrand factor type C module) from collagen IIA. J Biol Chem 2004; 279: 53857-66.
9. Zhang JL, Qiu LY, Kotzsch A, Weidauer S, Patterson L, Hammerschmidt M, Sebald W, Mueller TD. Crystal structure analysis reveals how the Chordin family member crossveinless 2 blocks BMP-2 receptor binding. Dev Cell 2008; 14: 739-50.
10. Marti T, Rosselet SJ, Titani K, Walsh KA. Identification of disulfide-bridged substructures within human von Willebrand factor. Biochemistry 1987; 26: 8099-109.
11. Bodo I, Katsumi A, Tuley EA, Eikenboom JC, Dong Z, Sadler JE. Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins. Blood 2001; 98: 2973-9.
12. van der Plas RM, Gomes L, Marquart JA, Vink T, Meijers JC, de Groot PG, Sixma JJ, Huizinga EG. Binding of von Willebrand factor to collagen type III: role of specific amino acids in the collagen binding domain of vWF and effects of neighboring domains. Thromb Haemost 2000; 84: 1005-11.
13. McKinnon TA, Chion AC, Millington AJ, Lane DA, Laffan MA. N-linked glycosylation of VWF modulates its interaction with ADAMTS13. Blood 2008; 111: 3042-9.
14. McKinnon TA, Goode EC, Birdsey GM, Nowak AA, Chan AC, Lane DA, Laffan MA. Specific N-linked glycosylation sites modulate synthesis and secretion of von Willebrand factor. Blood 2010; 116: 640-8.
15. Nowak AA, Canis K, Riddell A, Laffan MA, McKinnon TA. O-linked glycosylation of von Willebrand factor modulates the interaction with platelet receptor glycoprotein Ib under static and shear stress conditions. Blood 2012; 120: 214-22.
16. Wang JW, Valentijn KM, de Boer HC, Dirven RJ, van Zonneveld AJ, Koster AJ, Voorberg J, Reitsma PH, Eikenboom J. Intracellular storage and regulated secretion of von Willebrand factor in quantitative von Willebrand disease. J Biol Chem 2011; 286: 24180-8.
17. Kersteen EA, Raines RT. Catalysis of protein folding by protein disulfide isomerase and small-molecule mimics. Antioxid Redox Signal 2003; 5: 413-24.
18. Hatahet F, Ruddock LW. Protein disulfide isomerase: a critical evaluation of its function in disulfide bond formation. Antioxid Redox Signal 2009; 11: 2807-50.
19. Ellgaard L, Helenius A. Quality control in the endoplasmic reticulum. Nat Rev Mol Cell Biol 2003; 4: 181-91.
20. Molinari M, Galli C, Piccaluga V, Pieren M, Paganetti P. Sequential assistance of molecular chaperones and transient formation of covalent complexes during protein degradation from the ER. J Cell Biol 2002; 158: 247-57.
21. Caramelo JJ, Castro OA, Alonso LG, De Prat-Gay G, Parodi AJ. UDP-Glc: glycoprotein glucosyltransferase recognizes structured and solvent accessible hydrophobic patches in molten globule-like folding intermediates. Proc Natl Acad Sci USA 2003; 100: 86-91.
22. Caramelo JJ, Castro OA, de Prat-Gay G, Parodi AJ. The endoplasmic reticulum glucosyltransferase recognizes nearly native glycoprotein folding intermediates. J Biol Chem 2004; 279: 46280-5.
23. Fra AM, Fagioli C, Finazzi D, Sitia R, Alberini CM. Quality control of ER synthesized proteins: an exposed thiol group as a three-way switch mediating assembly, retention and degradation. EMBO J 1993; 12: 4755-61.
24. Kowalski JM, Parekh RN, Mao J, Wittrup KD. Protein folding stability can determine the efficiency of escape from endoplasmic reticulum quality control. J Biol Chem 1998; 273: 19453-8.
25. Kowalski JM, Parekh RN, Wittrup KD. Secretion efficiency in Saccharomyces cerevisiae of bovine pancreatic trypsin inhibitor mutants lacking disulfide bonds is correlated with thermodynamic stability. Biochemistry 1998; 37: 1264-73.
26. Molinari M, Calanca V, Galli C, Lucca P, Paganetti P. Role of EDEM in the release of misfolded glycoproteins from the calnexin cycle. Science 2003; 299: 1397-400.
27. Yadegari H, Driesen J, Pavlova A, Biswas A, Ivaskevicius V, Klamroth R, Oldenburg J. Insights into pathological mechanisms of missense mutations in C-terminal domains of von Willebrand factor causing qualitative or quantitative von Willebrand disease. Haematologica 2013; 98: 1315-23.
28. Legaz ME, Schmer G, Counts RB, Davie EW. Isolation and characterization of human factor VIII (antihemophilic factor). J Biol Chem 1973; 248: 3946-55.